These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35701754)

  • 1. Impaired mitochondrial accumulation and Lewy pathology in neuron-specific FBXO7-deficient mice.
    Noda S; Sato S; Fukuda T; Ueno S; Tada N; Hattori N
    Mol Brain; 2022 Jun; 15(1):54. PubMed ID: 35701754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and Function of Fbxo7/PARK15 in Parkinson's Disease.
    Randle SJ; Laman H
    Curr Protein Pept Sci; 2017; 18(7):715-724. PubMed ID: 26965690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of FBXO7 (PARK15) results in reduced proteasome activity and models a parkinsonism-like phenotype in mice.
    Vingill S; Brockelt D; Lancelin C; Tatenhorst L; Dontcheva G; Preisinger C; Schwedhelm-Domeyer N; Joseph S; Mitkovski M; Goebbels S; Nave KA; Schulz JB; Marquardt T; Lingor P; Stegmüller J
    EMBO J; 2016 Sep; 35(18):2008-25. PubMed ID: 27497298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homeostatic p62 levels and inclusion body formation in CHCHD2 knockout mice.
    Sato S; Noda S; Torii S; Amo T; Ikeda A; Funayama M; Yamaguchi J; Fukuda T; Kondo H; Tada N; Arakawa S; Watanabe M; Uchiyama Y; Shimizu S; Hattori N
    Hum Mol Genet; 2021 Apr; 30(6):443-453. PubMed ID: 33631794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of FBXO7 results in a Parkinson's-like dopaminergic degeneration via an RPL23-MDM2-TP53 pathway.
    Stott SR; Randle SJ; Al Rawi S; Rowicka PA; Harris R; Mason B; Xia J; Dalley JW; Barker RA; Laman H
    J Pathol; 2019 Oct; 249(2):241-254. PubMed ID: 31144295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new mutation in the Parkinson's-related FBXO7 gene impairs mitochondrial and proteasomal function.
    Navarro E; Esteras N
    FEBS J; 2024 Jun; 291(12):2562-2564. PubMed ID: 38708447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gsk3β and Tomm20 are substrates of the SCFFbxo7/PARK15 ubiquitin ligase associated with Parkinson's disease.
    Teixeira FR; Randle SJ; Patel SP; Mevissen TE; Zenkeviciute G; Koide T; Komander D; Laman H
    Biochem J; 2016 Oct; 473(20):3563-3580. PubMed ID: 27503909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A sporadic Parkinson's disease model via silencing of the ubiquitin-proteasome/E3 ligase component, SKP1A.
    Fishman-Jacob T; Youdim MBH
    J Neural Transm (Vienna); 2024 Jun; 131(6):675-707. PubMed ID: 37644186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linking F-box protein 7 and parkin to neuronal degeneration in Parkinson's disease (PD).
    Zhou ZD; Sathiyamoorthy S; Angeles DC; Tan EK
    Mol Brain; 2016 Apr; 9():41. PubMed ID: 27090516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. USP7 attenuates endoplasmic reticulum stress-induced apoptotic cell death through deubiquitination and stabilization of FBXO7.
    Lee SH; Chung KC
    PLoS One; 2023; 18(10):e0290371. PubMed ID: 37874827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FBXO7 triggers caspase 8-mediated proteolysis of the transcription factor FOXO4 and exacerbates neuronal cytotoxicity.
    Lee SH; Jung S; Lee YJ; Hyun M; Chung KC
    J Biol Chem; 2021 Dec; 297(6):101426. PubMed ID: 34800438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiological mechanisms linking F-box only protein 7 (FBXO7) and Parkinson's disease (PD).
    Zhou ZD; Lee JCT; Tan EK
    Mutat Res Rev Mutat Res; 2018; 778():72-78. PubMed ID: 30454685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FBXO7 immunoreactivity in α-synuclein-containing inclusions in Parkinson disease and multiple system atrophy.
    Zhao T; Severijnen LA; van der Weiden M; Zheng PP; Oostra BA; Hukema RK; Willemsen R; Kros JM; Bonifati V
    J Neuropathol Exp Neurol; 2013 Jun; 72(6):482-8. PubMed ID: 23656991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of Parkinson's disease-related gene Fbxo7 is associated with impaired mitochondrial metabolism by PARP activation.
    Delgado-Camprubi M; Esteras N; Soutar MP; Plun-Favreau H; Abramov AY
    Cell Death Differ; 2017 Jan; 24(1):120-131. PubMed ID: 27689878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The F-box protein FBXO7 positively regulates bone morphogenetic protein-mediated signaling through Lys-63-specific ubiquitination of neurotrophin receptor-interacting MAGE (NRAGE).
    Kang J; Chung KC
    Cell Mol Life Sci; 2015 Jan; 72(1):181-95. PubMed ID: 24947323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E3 ligase adaptor FBXO7 contributes to ubiquitination and proteasomal degradation of SIRT7 and promotes cell death in response to hydrogen peroxide.
    Lee SH; Lee YJ; Jung S; Chung KC
    J Biol Chem; 2023 Mar; 299(3):102909. PubMed ID: 36646384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cullin-RING ubiquitin ligase targets exogenous α-synuclein and inhibits Lewy body-like pathology.
    Gerez JA; Prymaczok NC; Rockenstein E; Herrmann US; Schwarz P; Adame A; Enchev RI; Courtheoux T; Boersema PJ; Riek R; Peter M; Aguzzi A; Masliah E; Picotti P
    Sci Transl Med; 2019 Jun; 11(495):. PubMed ID: 31167929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of nuclear REST/NRSF in aged-dopaminergic neurons in Parkinson's disease patients.
    Kawamura M; Sato S; Matsumoto G; Fukuda T; Shiba-Fukushima K; Noda S; Takanashi M; Mori N; Hattori N
    Neurosci Lett; 2019 Apr; 699():59-63. PubMed ID: 30684677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The characteristics of FBXO7 and its role in human diseases.
    Zhong Y; Li J; Ye M; Jin X
    Gene; 2023 Jan; 851():146972. PubMed ID: 36261086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FBXO7 Y52C polymorphism as a potential protective factor in Parkinson's disease.
    Chen CM; Chen IC; Huang YC; Juan HF; Chen YL; Chen YC; Lin CH; Lee LC; Lee CM; Lee-Chen GJ; Lai YJ; Wu YR
    PLoS One; 2014; 9(7):e101392. PubMed ID: 25029497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.